Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
NEURO RIV NT is a fixed-dose combination sustained-release tablet developed by Rivchem Pharmaceuticals for the management of neuropathic pain, such as diabetic neuropathy, postherpetic neuralgia, and spinal cord injury. The formulation combines three active ingredients with complementary mechanisms: pregabalin, nortriptyline, and methylcobalamin. Pregabalin is an alpha-2-delta ligand that binds to voltage-gated calcium channels in the central nervous system, reducing calcium influx and the subsequent release of excitatory neurotransmitters. Nortriptyline is a tricyclic antidepressant that inhibits the reuptake of norepinephrine and serotonin, thereby enhancing descending inhibitory pain pathways. Methylcobalamin, an active coenzyme form of vitamin B12, acts as a cofactor for methionine synthase, promoting myelin sheath synthesis, axonal regeneration, and nerve repair.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Follow clinical development from study design and recruitment through results.
Explore development by indication, patient population, and geography.
Trace asset ownership, licensing agreements, and commercial partnerships.
Explore the patent landscape and regulatory exclusivity around an asset.
Compare development programs by target, modality, and indication.
Connect source evidence and development news to your research questions.
See how Gosset can support your research on methylcobalamin + nortriptyline + pregabalin (Rivchem Pharmaceuticals).